We are live on ! Find out more
DMTK

DermTech, Inc. Common Stock

Delisted

DMTK was delisted on the 26th of June, 2024.

21 hedge funds and large institutions have $109M invested in DermTech, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

75% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 4

23% more capital invested

Capital invested by funds: $89.1M → $109M (+$20.1M)

11% more funds holding

Funds holding: 1921 (+2)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
21
Holders Change
+2
Holders Change %
+10.53%
% of All Funds
0.48%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
4
Increased
7
Reduced
4
Closed
2
Calls
Puts
Net Calls
Net Calls Change

DMTK Hedge Fund Activity: Q1 2018 in Review

21 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q1 2018, worth a combined $109M — up 23% from $89.1M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new DMTK positions and 2 closed out — a net gain of 2 holders — while 7 added to existing stakes and 4 trimmed.

The largest buyer was Polar Asset Management Partners, adding an estimated $14.7M. The largest seller was Boothbay Fund Management, cutting an estimated $5.39M.

  • 21 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q1 2018, up from 19 in Q4 2017.
  • Funds reported $109M of DermTech, Inc. Common Stock stock for Q1 2018, up 23% quarter-over-quarter.
  • 4 funds opened new DermTech, Inc. Common Stock positions in Q1 2018 and 2 closed out, a net change of +2 holders.
  • The largest DermTech, Inc. Common Stock buyer in Q1 2018 was Polar Asset Management Partners, an estimated $14.7M added.
  • The largest DermTech, Inc. Common Stock seller in Q1 2018 was Boothbay Fund Management, an estimated $5.39M sold.

Based on aggregated 13F filings for Q1 2018.